RWA Wealth Partners’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.16M Buy
165,231
+1,772
+1% +$44.7K 0.04% 191
2026
Q1
$4.13M Sell
163,459
-3,738
-2% -$95.4K 0.05% 187
2025
Q4
$4.27M Buy
167,197
+8,746
+6% +$224K 0.05% 181
2025
Q3
$4.06M Buy
158,451
+3,947
+3% +$100K 0.05% 193
2025
Q2
$3.91M Buy
154,504
+3,257
+2% +$80.8K 0.05% 182
2025
Q1
$3.78M Buy
151,247
+17,577
+13% +$435K 0.05% 173
2024
Q4
$3.29M Buy
133,670
+116,666
+686% +$2.92M 0.04% 197
2024
Q3
$437K Buy
+17,004
New +$429K 0.01% 417

Other funds holding IBDX

RWA Wealth Partners's IBDX Position: Q2 2026 in Review

RWA Wealth Partners increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 1.1% in Q2 2026, buying an estimated $44.7K and bringing the position to 165,231 shares worth $4.16M. The position accounts for 0.04% of the portfolio, ranked #191.

RWA Wealth Partners first reported a position in IBDX in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.27M in Q4 2025. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • RWA Wealth Partners held 165,231 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $4.16M as of Q2 2026.
  • RWA Wealth Partners bought 1,772 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $44.7K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.04% of RWA Wealth Partners's portfolio in Q2 2026, its #191 holding.
  • RWA Wealth Partners first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2024 and has held it in 8 quarters since.
  • RWA Wealth Partners's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $4.27M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.